Research Only
Selank + Semax 50mg Total (25mg + 25mg) AQ Pen
This equal-mass 3mL pen combines Selank, a tuftsin-derived heptapeptide, with Semax, an ACTH(4-7)-Pro-Gly-Pro heptapeptide. The compounds have separate preclinical research histories, and no evidence for a distinct fixed-combination effect is supplied. No batch-specific independent report is linked, so sequence, component identity, quantity and purity are unverified.
Compound: Selank + Semax
Catalogue strength: 50 mg total (25 mg + 25 mg)
Format: Aqueous pre-filled pen
Storage: Follow the Genovare package label.
- Pack Size
- 3mL
- Product details
- Genovare Catalogue
- Pre-Filled Pen
- Premixed Aqueous
- Storage Guidance
- Follow Package Label
What Is Included
- 1 pre-filled Genovare research pen
- 3 pen needles
- Genovare retail packaging
Genovare · Pre-Filled Pen · Premixed Aqueous
Selank + Semax 50mg Total (25mg + 25mg) AQ Pen
50 mg total (25 mg + 25 mg) · Aqueous pre-filled pen
AED 1,100
Out of stock
- Sold by
- Remy Peptides
- Brand
- Genovare
- Manufacturer
- Genovare
- Tested by
- Independent testing not supplied
Technical Specifications
| Manufacturer | Genovare |
|---|---|
| Compound | Selank + Semax |
| Catalogue strength | 50 mg total (25 mg + 25 mg) |
| Fill volume | 3mL |
| Format | Aqueous pre-filled pen |
| Pack size | 1 pen with 3 needles |
| Independent testing | Not supplied |